Table 10.

Betweenness of promising drug candidates on the validation network.

Rank	Drug name	Betweenness
1	Tamoxifen∗	172
2	Paclitaxel∗	37
3	Doxorubicin∗	32
4	Camptothecin∗∗	13
5	Exemestane∗	13
6	Fulvestrant∗	12
7	Methotrexate∗	10
8	Vinblastine∗	6
9	Megestrol∗	6
10	Aminoglutethimide∗	2
11	Letrozole∗	2
12	MS-275∗∗	2
13	GW-8510∗∗	0
14	Phenoxybenzamine∗∗	0
15	Tyrphostin_AG-825∗∗	0
16	Alsterpaullone∗∗	0
17	Celastrol∗∗	0

^∗Known breast cancer drug. ^∗∗Potential drug candidate for repositioning.